Fighting the opioid crisis requires a comprehensive, sustainable approach and we believe that everyone can play an important part in charting a better path forward for victims, families, and communities across the country. The Clinton Foundation works to bring together diverse groups of stakeholders to implement solutions aimed at reversing the crisis and increasing access to naloxone and other lifesaving resources by expanding our work with schools, faith leaders, employers, and insurers.
In 2015 and 2016, the Clinton Foundation negotiated innovative agreements with kaléo and Adapt Pharma, respectively, to decrease cost and increase access to both injectable and nasal spray forms of naloxone, an opioid overdose antidote. These partnerships made naloxone available at a discounted price to colleges and universities, public safety organizations, and community organizations, and through its partnership with Adapt Pharma, NARCAN (naloxone in spray form) is available to high schools, colleges, and universities at no cost. To date, 3,600 schools have received NARCAN through this program.
To date, the Clinton Foundation has helped to distribute more than 50,000 doses of naloxone across the country. The Clinton Foundation will continue working to increase access to this lifesaving medication and help get it in the hands of those who can intervene quickly during an overdose emergency.